article · Nigerian Journal of Biotechnology
Tomato mosaic virus (ToMV) is among the most devastating viral diseases of tomato worldwide and it can cause yield losses of up to 40%. One of the effective managements of plant viral diseases is the use of resistant genotypes. This research was conducted to determine the reaction of tomato genotypes to Tomato mosaic virus (ToMV) infection. The experiment consists of five tomato genotypes which were evaluated for resistance to ToMV infection under screen-house conditions using Completely Randomized Design (CRD) with three replicates. The treatments were Dantaya, Danwarai, Dan-Niko, Dan-Heka, and Hybrid Platinum, which are the five most preferred farmers varieties in Kebbi State. Prior to mechanical inoculation, ToMV-infected leaf samples used as source of inoculum were tested ToMV positive using Direct Antibody Coating-Enzyme Linked Immunoassay (DAC-ELISA). Thirty-six (36) seedlings of each genotype were transplanted into plastic pots containing compost and seedlings recovery were recorded two weeks after transplanting (WAT) before inoculation. Hybrid Platinum has low establishment percentage (72.22%), compared to DanHeka and Dan-Niko with both 100%. All the genotypes evaluated were infected when inoculated with ToMV but with significant variation (P = 0.05) in their reaction to ToMV infection. Dantaya recorded the highest percent disease incidence of 50.00% while, Platinum recorded the lowest percent disease incidence of 31.94%. Three genotypes were susceptible to ToMV while, two were resistant to ToMV. The high incidence of ToMV found on farmers preferred tomato genotypes in Kebbi State is of great management concern. Also, this has implication for tomato productivity and yield in the state.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4314/njb.v40i1.1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.